Please log in
to access more information

loading...

User name and Password not recognised

Home Page > News > Diary Dates

Schilddrüsen Kongress 2019

We will be in Munich during the 2019 Schilddrüsen Congress during which we are expecting more than 300 participants to attend our lunch symposium. 

 

A new type of bleeding control in thyroid surgery

Thursday, June 6th, 2019
Hörsaal Frauenklinik Maistrasse
Maistrasse 11
80337 München
Germany

PROGRAM

  • 12:30 – 12:45:

Moderation / Introduction
Professor Dr. med. M. Spannagl
LMU Klinikum der Universität München, Campus Großhadern und Innenstadt

  • 12:45 – 13:00:

Postoperative bleeding in thyroid surgery and treatment / prevention
Prof. Dr. med. P. Goretzki
Charite Universitätsmedizin Berlin

  • 13:00 – 13:15:

Hemostyptics for thyroid surgery in patients at risk of re-bleeding - Use or waste?
PD Dr. med. S. Schopf
Krankenhaus Agatharied

  • 13:15 – 13:30:

The perioperative risk of bleeding complication (best practice)
Prof. Dr. med. U.  Mittelkötter
Katharinen Hospital Unna

» Download the program (in German)


36th UNAIBODE National Days of Studies and Improvement

We welcome you from May 15th to 17th at the Pierre Baudis Congress Center in Toulouse (stand E11) to the 36th UNAIBODE National Days of Studies and Improvement.

"AN IBODE ODYSSEY" - The latest scientific advances in surgical procedures will be presented during these themed days giving Biom'up a great opportunity to showcase Hemoblast™ Bellows its new bleeding management solution.

More information (french website)


EUROPEAN EDUCATIONAL SYMPOSIUM AND HANDS-ON SESSION IN VIENNA

On April 10th and 11th we gathered 30 people including 15 surgeons as well as distributors and prospects at the Medical University of Vienna, for 3 hands-on sessions covering the use of HEMOBLAST™ Bellows in the following specialties:

 

  • Cardiac surgery
  • General surgery
  • Laparoscopic surgery

 

This European event was led by our Chief Medical Officer, William SPOTNITZ, M.D., M.B.A while the hands-on sessions were conducted by Roberto Manson, M.D., VP of Surgical Education.

Among participants, we had the chance to include two International Key Opinion Leaders :

 

 

Discover HEMOBLAST™ Bellows


136th German Society of Surgery Congress - DCK 2019

We'll be in Munich at the 136th Gesellschaft für Chirurgie, the German Society of Surgery Congress, from March 26 to 29, 2019. 


19th Journées du Club Cœlio, Orléans (France)

We'll be in Orléans, France at the 19th Journées du Club Cœlio. Join us on Friday March 15 and Saturday March 16 at the Centre hospitalier régional d'Orléans.

The program will include the following talk by Dr Alain Valverde, Chief of Visceral Surgery at Groupe Hospitalier Diaconesses Croix Saint-Simon : Risk and bleeding management in liver surgery


Le Choix des Armes convention

Join us at the 30th Le Choix des Armes convention from Thursday March 14 to Saturday March 16 in Marseille's (France) Fort Ganteaume. 

Find out more on (french only) lechoixdesarmes.org


[WEB SESSION] Bleeding and Hemostasis Management in Cardiac Surgery

Many visitors have joined us on Tuesday March, 5th 2019 for the latest PCI (Pitié cardiac institute) international web session, an event proposed by Pr Pascal Leprince, Chief of Cardiac Surgery at La Pitié-Salpêtrière and sponsored by Biom'up. 

 

►  Watch the full replay of the web session (registration required).

 

PROGRAM

6:30 - Introduction
Pascal LEPRINCE - M.D., PhD - Sorbonne University, Chief of Cardiac surgery Pitié-Salpêtrière

6:35 - Risk assessment and management before surgery
Adrien BOUGLÉ - M.D., PhD - Sorbonne University, Anesthesiologist and Surgical Intensive Care Unit, Pitié-Salpêtrière

6:50 - Per and Post operative Bleeding issues during surgery and Presentation of case study with HEMOBLAST™ Bellows (movie)
Guillaume LEBRETON - M.D., PhD - Sorbonne University, Cardiovascular and Thoracic Surgery, Pitié-Salpêtrière

7:05 - SPOT GRADE™ and Presentation of HEMOBLAST™ Bellows PMA results
William SPOTNITZ - M.D., M.B.A - Chief Medical Officer, Biom’up Professor of Surgery, Univ. of Virginia

7:25 - Conclusion
Bertrand ROZEC - M.D., PhD - Anesthesiology and Intensive Care, Centre Hospitalier Universitaire de Nantes

» Download the program


OFFICIAL LAUNCH OF HEMOBLAST™ BELLOWS IN SPAIN

Today, Thursday January 24th, Biom’up and Palex have launched Hemoblast Bellows into the Spanish market at a kick-off meeting in Barcelona (Spain). All surgical sales and marketing  staff  of Palex Medical were educated on HEMOBLAST Bellows, a hemostatic powder to control bleeding in a broad range of both traditional and laparoscopic surgical procedures, such as cardiac, general and orthopedic surgeries, and give patients a better quality of life.

The session included hands-on application of Hemoblast Bellows by every participant, an expert round table on its benefits in Cardio-thoracic, spine and laparoscopic surgeries, as well as clinical data and commercial discussions.   

Carlos Chordá, General Manager of Palex Medical, a leading medical device distributor in the Iberian Peninsula, based in Barcelona and Madrid, opened the session with his team emphasizing the broad range of indications that Hemoblast Bellows will be used in. The program was led by Prof. William Spotnitz, Biom’up Chief Medical Officer in collaboration with key  surgeons who are using HEMOBLAST Bellows successfully in their surgical routine  and clinical trials, Dr. Thierry Barthes (Abdominal and Laparoscopic Surgeon, Polyclinic of Poitiers, France), Dr. Pierre-Marie Longis (Spine Surgeon, Private Hospital of Confluent, Nantes, France) and Dr. Alexandros Paraforos (Chief Consultant and Deputy Medical Director, Department of Cardio-Thoracic Surgery, Trier, Germany).

Prof. William Spotnitz comments on the session: « Wonderfully informative, innovative, and cooperative meeting, with a lot of interaction and helpful discussion ».

Through its comprehensive sales network covering Spain’s main hospitals, Palex will contribute to an important commercial breakthrough for Biom’up. The Spanish market for topical hemostats is one of the largest in the European Union, estimated to have reached €75m and growing at 5% annually (source: Grand View Research)